erythropoeitin

DRUG2 trials

Sponsors

Brigham and Women's Hospital, National Institute of Neurological Disorders and Stroke (NINDS)

Conditions

Contrast Induced NephropathyTraumatic Brain Injury

Phase 2

Effect of Recombinant Erythropoietin on Numbers of Circulating Endothelial Progenitor Cells in People With Persistent Symptoms During the Subacute Period After Traumatic Brain Injury

WithdrawnNCT02226848

National Institute of Neurological Disorders and Stroke (NINDS)Traumatic Brain Injury

Start: 2014-08-15End: 2017-05-31Updated: 2018-07-05

Phase 4

Erythropoietin in Radiocontrast Induced Nephropathy (ERIN) Trial

TerminatedNCT00476619

Brigham and Women's HospitalContrast Induced Nephropathy

Start: 2004-09-30End: 2008-06-30Updated: 2009-04-06